KR Choksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2472 in its research report dated February 13, 2025.

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

Ten semifinal matchups are on tap Friday, including a doubleheader at Newman’s Michael Lupin Field, where the Greenies look to put their boys and girls teams in the Division IV final.

Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...

Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2420 in its ...

Lupin Ltd (BOM:500257) reports its highest EBITDA margin in five years, driven by strong performance across key markets and strategic acquisitions.

Nuvama recommends 'Buy' for SAIL, Berger Paints, Muthoot Finance, and Lupin. Explore these stocks' growth potential amid ...

Exclusive with CFO Ramesh Swaminathan. Lupin has reported a robust Q3 FY25 performance, showcasing double-digit sales growth ...

Ramesh Swaminathan, Global CFO of pharmaceutical company Lupin, warns that Trump tariffs could deny many in the U.S. access ...

Domestic, as well as global brokerages are optimistic about Lupin's future, citing strong earnings visibility and a promising ...

I felt like saying, ‘You know, I was in ‘Narnia,’ not ‘Harry Potter,’ right? Do you understand that I was not in these films?

It's hard to believe, but later this year we'll be watching Avatar: Fire and Ash, the forthcoming third movie in James ...